Intexso Biochem Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 3.30 Cr
as on 15-11-2024
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 16.78 Cr
as on 15-11-2024
- Satisfied Charges ₹ 8.00 M
as on 15-11-2024
- Revenue 11.63%
(FY 2023)
- Profit -24.36%
(FY 2023)
- Ebitda -0.21%
(FY 2023)
- Net Worth 15.43%
(FY 2023)
- Total Assets 29.98%
(FY 2023)
About Intexso Biochem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.30 Cr.
The company currently has active open charges totaling ₹16.78 Cr. The company has closed loans amounting to ₹8.00 M, as per Ministry of Corporate Affairs (MCA) records.
Hari Shetty, Vinodkumar Naganur, Suchitra Naganur, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24119MH2009PTC194970
- Company No.
194970
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Aug 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Intexso Biochem Private Limited offer?
Intexso Biochem Private Limited offers a wide range of products and services, including Flavours & Aromatics, Food Enzymes, Industrial Chemicals & Supplies, Surfactants, Textile, Dyeing & Finishing Chemical, Textile Enzymes, Chemical Reagents & Catalysts, Chemical Test Kits, FRP Lining, PU & Powder Coatings, Special Coating.
Who are the key members and board of directors at Intexso Biochem?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hari Shetty  | Director | 01-Jun-2015 | Current |
| Vinodkumar Naganur | Director | 17-Aug-2009 | Current |
| Suchitra Naganur | Director | 17-Aug-2009 | Current |
| Avinash Orpe | Director | 17-Aug-2009 | Current |
| Chhaya Orpe | Director | 17-Aug-2009 | Current |
| Shoma Shetty | Director | 01-Jun-2015 | Current |
Financial of Intexso Biochem.
Intexso Biochem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.63% increase. The company also saw a substantial fall in profitability, with a 24.36% decrease in profit. The company's net worth Soared by an impressive increase of 15.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Intexso Biochem?
In 2023, Intexso Biochem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 19 Sep 2016 | ₹16.78 Cr | Open |
Others Creation Date: 13 Apr 2015 | ₹8.00 M | Satisfied |
How Many Employees Work at Intexso Biochem?
Unlock and access historical data on people associated with Intexso Biochem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intexso Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intexso Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
